Search
Experience a remarkable portrait of Black history in America through the family story of Dr. Selwyn Vickers, the President and CEO of Memorial Sloan Kettering Cancer Center.
A multicenter study led by Memorial Sloan Kettering researchers has answered an important question about the safety of using carbon nanotubes in medicine.
Meet Cancer Engineering MD-PhD candidate Brandon Cuevas: “Being able to be a bridge between medicine and research is such a privilege, one that not many places can offer.”
Dr. Hedvig Hricak is leading an international commission calling for a global strategy on improving access to more effective cancer care.
During meiosis, small chromosomes risk being lost in the shuffle. Here’s how they hold their own.
A new pancreatic cancer research center has been created at Memorial Sloan Kettering Cancer Center (MSKCC). The ambitious initiative was established with an initial commitment of $10 million from MSKCC Board member David M. Rubenstein.
As construction began on the Mortimer B. Zuckerman Research Center, SKI adopted new ways to advance therapeutic innovation at Memorial Sloan Kettering.
Nearly every advance in cancer care today is possible because of clinical trials. MSK is breaking down the age barrier that has made it hard for young patients such as Irving Romero Torres to participate in and benefit from clinical research.
For HER2-positive breast cancers, MRI scans that employ machine-learning algorithms can provide more guidance than biopsies alone.
MSK researchers shed light on the signals that determine the fate of embryonic cells.